Idorsia increases the consent fee in connection with the proposed restructuring of the 2024 convertible bond
May 01, 2024 12:00 ET
|
Idorsia Pharmaceuticals Ltd
Ad hoc announcement pursuant to Art. 53 LR The proposed consent fee will be increased to 8’000’000 Idorsia shares. All other matters as proposed on April 23, 2024, remain unchanged.The bondholder...
Idorsia increases the consent fee in connection with the proposed restructuring of the 2024 convertible bond
May 01, 2024 12:00 ET
|
Idorsia Pharmaceuticals Ltd
Ad hoc announcement pursuant to Art. 53 LR The proposed consent fee will be increased to 8’000’000 Idorsia shares. All other matters as proposed on April 23, 2024, remain unchanged.The bondholder...
Sustainability Report 2023 published – Feintool receives strong ESG rating
May 01, 2024 00:30 ET
|
Feintool International Holding AG
Feintool plays a shaping role in the transition to the low-carbon economy. The Group supports systematic development of young talent and leadership, develops innovative products to advance the green...
Nachhaltigkeitsbericht 2023 publiziert – Feintool punktet bei ESG-Rating
May 01, 2024 00:30 ET
|
Feintool International Holding AG
Feintool ist ein wichtiger Player beim Übergang zu einer CO2-armen Wirtschaft. Wie der neue Nachhaltigkeitsbericht für das Geschäftsjahr 2023 dokumentiert, stützt das Unternehmen mit innovativen...
ArcelorMittal announces results of its General Meeting
April 30, 2024 12:15 ET
|
ArcelorMittal S.A.
30 April 2024, 18:15 CET The Annual General Meeting (‘General Meeting’) of shareholders of ArcelorMittal held today in Luxembourg approved all resolutions by a strong majority. 78.47% of the voting...
Shareholders approve all resolutions proposed by Board of Directors at Annual General Meeting of Sandoz Group AG
April 30, 2024 06:25 ET
|
Sandoz Group
All proposals of Board of Directors approvedGilbert Ghostine re-elected as Chairman of Board of Directors; all other Board members standing for election confirmedMathai Mammen, Graeme Pitkethly...
Sandoz reaches agreement with Amgen resolving all patent litigation related to its US denosumab biosimilars
April 30, 2024 01:00 ET
|
Sandoz Group
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Sandoz reaches agreement with Amgen resolving all patent litigation related to its US denosumab biosimilars Agreement...
Clariant delivers good start to 2024 with improved profitability – outlook confirmed
April 30, 2024 01:00 ET
|
Clariant International Ltd
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Q1 2024 sales decreased by 6 % organically in local currencies1 to CHF 1.014 billion against a strong comparison base in Q1 2023, driven by...
WISeKey International Holding Ltd Receives Extension of the Deadline for the Publication of its FY 2023 Annual Report and Releases Unaudited FY 2023 Key Metrics
April 30, 2024 01:00 ET
|
Wisekey International Holding Ltd.
Zug, Switzerland, April 30, 2024 (GLOBE NEWSWIRE) -- Also Files Form 12b-25 with SEC Related to Annual Report on Form 20-F Ad hoc announcement pursuant to Art. 53 of SIX Listing Rules – WISeKey...
Molecular Partners Announces Publication in Cancer Immunology Research of Preclinical Data Supporting MP0533’s Proposed Mechanism of Action
April 29, 2024 11:00 ET
|
Molecular Partners
Preclinical data of tetra-specific T cell engager MP0533 demonstrate preferential T cell mediated killing of AML cells, while sparing healthy cellsResults highlight MP0533-mediated T-cell activation...